Diffuse Large B-cell Lymphoma during Corticosteroid Therapy for TAFRO Syndrome. - Wikidata - awgldk - TriplyDB

Diffuse Large B-cell Lymphoma during Corticosteroid Therapy for TAFRO Syndrome.

Diffuse Large B-cell Lymphoma during Corticosteroid Therapy for TAFRO Syndrome.

http://www.wikidata.org/entity/Q33435903

about

Clinicopathological features of progressive renal involvement in TAFRO syndrome: A case report and literature review.A comparison of TAFRO syndrome between Japanese and non-Japanese cases: a case report and literature review.

P2860

Q41927889-EE40B2C9-5316-4366-A642-BC1B150468DD Q41928746-872EDDDF-B4E0-47CC-989A-73F27F86A21D

P2860

Diffuse Large B-cell Lymphoma during Corticosteroid Therapy for TAFRO Syndrome.

http://www.wikidata.org/entity/Q33435903

description

2016 nî lūn-bûn

@nan

2016 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Diffuse Large B-cell Lymphoma during Corticosteroid Therapy for TAFRO Syndrome.

@ast

Diffuse Large B-cell Lymphoma during Corticosteroid Therapy for TAFRO Syndrome.

@en

type

label

Diffuse Large B-cell Lymphoma during Corticosteroid Therapy for TAFRO Syndrome.

@ast

Diffuse Large B-cell Lymphoma during Corticosteroid Therapy for TAFRO Syndrome.

@en

prefLabel

Diffuse Large B-cell Lymphoma during Corticosteroid Therapy for TAFRO Syndrome.

@ast

Diffuse Large B-cell Lymphoma during Corticosteroid Therapy for TAFRO Syndrome.

@en

P1433

Q33435903-5CD26633-6B36-4CDE-8929-FD73DEAEFA77

P1476

Q33435903-B2621FB9-5399-4314-8680-4F6832684E60

P2093

Q33435903-2FB48E35-EDC6-42F9-A086-E4274BE11FDE

Q33435903-534D0450-85ED-4EAF-8806-B99A1219AF67

Q33435903-7BED5411-4603-4080-BF11-68EF9BEF9024

Q33435903-962A305C-6384-48AA-A93B-71A71480FA28

P2860

Q33435903-04069801-D4C1-4020-8655-F6BB5BE63D36

Q33435903-0531B223-7CF1-4B22-ACA9-0BA0561338B4

Q33435903-1BE419F8-90C8-493F-BBA6-9D0C9F3FE9E8

Q33435903-2F082ACC-C5A0-43D8-A9FF-C75924A358D8

Q33435903-3F7207B4-FF2F-48FF-B610-1F7C3D20F3D3

Q33435903-5BD37F8C-AA31-49C4-8072-9DE9E6E23C4A

Q33435903-639C0A5B-FF86-4EE0-AB68-B511DBE7FEA1

Q33435903-66416208-385B-41A3-8A38-FE4B9069B54D

Q33435903-7513C16B-3954-4305-A422-59705A049E80

Q33435903-76F41DF5-A8BE-4D92-B221-BFF360520F99

P304

Q33435903-03115EE7-E48D-4D15-AF3F-DF1B6C264951

P31

Q33435903-129d5ae2-af91-498d-8a92-937cc32e0c31

Q33435903-1D8ACADC-EE28-4803-8FE3-374CEC773473

P356

Q33435903-82B94B5A-8801-4F1C-8C69-2E07EA94E9F9

P433

Q33435903-9B3DB83E-5679-484D-BB99-416DAFC639E2

P478

Q33435903-2B610FE4-145C-453E-BC0D-B78A851A930C

P577

Q33435903-92356A85-86B2-4C3A-A67A-6CD9486EC5DD

P698

Q33435903-DF9EAEB8-7BB5-4573-A45A-2DE110F20888

P932

Q33435903-3A60411E-77C7-4894-BC1F-9A72B625B336

P356

INTERNALMEDICINE.55.6455

P1433

Internal Medicine

P1476

Diffuse Large B-cell Lymphoma during Corticosteroid Therapy for TAFRO Syndrome.

@en

P2093

Eiko Ohya

http://www.w3.org/2001/XMLSchema#string

Haruna Sakaguchi

http://www.w3.org/2001/XMLSchema#string

Minoru Mizutani

http://www.w3.org/2001/XMLSchema#string

Takao Sekine

http://www.w3.org/2001/XMLSchema#string

P2860

Complete resolution of TAFRO syndrome (thrombocytopenia, anasarca, fever, reticulin fibrosis and organomegaly) after immunosuppressive therapies using corticosteroids and cyclosporin A : a case report.

Angioimmunoblastic T cell lymphoma associated with reversible myelofibrosis.

[Thrombocytopenia with mild bone marrow fibrosis accompanied by fever, pleural effusion, ascites and hepatosplenomegaly].

Japanese variant of multicentric castleman's disease associated with serositis and thrombocytopenia--a report of two cases: is TAFRO syndrome (Castleman- Kojima disease) a distinct clinicopathological entity?

Atypical hyaline vascular-type castleman's disease with thrombocytopenia, anasarca, fever, and systemic lymphadenopathy.

Successful treatment of a patient with multicentric Castleman's disease who presented with thrombocytopenia, ascites, renal failure and myelofibrosis using tocilizumab, an anti-interleukin-6 receptor antibody.

[Efficacy of rituximab for TAFRO syndrome, a variant type of multicentric Castleman's disease].

Successful treatment of a Caucasian case of multifocal Castleman's disease with TAFRO syndrome with a pathophysiology targeted therapy - a case report.

A systemic lymphoproliferative disorder with morphologic features of Castleman's disease: clinical findings and clinicopathologic correlations in 15 patients.

Localized mediastinal lymphnode hyperplasia resembling thymoma.

P304

2861-2867

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2169/INTERNALMEDICINE.55.6455

http://www.w3.org/2001/XMLSchema#string

P433

19

http://www.w3.org/2001/XMLSchema#string

P478

55

http://www.w3.org/2001/XMLSchema#string

P577

2016-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27725549

http://www.w3.org/2001/XMLSchema#string

P932

5088550

http://www.w3.org/2001/XMLSchema#string